You are currently viewing archive.bio.org. Head to our home page to check out our fresh new look!

BIO Announces a Special Preconference Workshop: Outlook on Federal Policy Affecting Advanced Biofuels and Renewable Chemicals

Apr 28 2014
BIO’s World Congress on Industrial Biotechnology’s pre-conference Workshop, “U.S. Policy Outlook: From the RFS to Tax Reform to Farm Bill Implementation - What Lies Ahead for Advanced Biofuels and Renewable Chemicals?”.   The workshop is designed to assess the threats and opportunities on the U.S. federal policy landscape for 2014.

2014 BIO International Convention Super Sessions to Address Advancements in Oncology, the State of the Industry and the Accelerating Medicines Partnership

Apr 23 2014
The 2014 BIO International Convention® will include six timely and dynamic Super Sessions featuring prominent biotech thought leaders.  This year’s sessions will cover issues from the state of the biotech industry to transforming the world of healthcare.  

BIO Announces Cleantech Investor Speakers for 2014 World Congress on Industrial Biotechnology

Apr 21 2014
selective group of CEOs and COOs from emerging industrial biotechnology companies will present new technologies, accomplishments, and business cases during the Clean Tech Investor Sessions at the BIO World Congress on Industrial Biotechnology. 

BIO Applauds White House Support for Agricultural Biotechnology

Apr 16 2014
As a follow-up to the March 25th dedication of the Norman E. Borlaug statue in the U.S. Capitol’s National Statuary Hall, President Obama praised the work of the Nobel Prize winner and voiced support for the promises of agricultural biotechnology.

Academic and Research Institutions to Play Key Role in 2014 BIO International Convention®

Apr 15 2014
The 2014 BIO International Convention® will highlight the role of academia in the advancement of the biotechnology field through the BIO Alliance Pavilion and the Translational Research Forum. Hosted by the Biotechnology Industry Organization (BIO), the global event for biotechnology will take place June 23-26, 2014 at the San Diego Convention Center in San Diego, California.

Registration for the 2014 BIO Livestock Biotech Summit Now Open

Apr 14 2014
Registration for this year’s Livestock Biotech Summit is officially open to attendees and credentialed media, the Biotechnology Industry Organization (BIO) announced today.  The BIO Livestock Biotech Summit will be September 16-18, 2014, at the Sioux Falls Convention Center in Sioux Falls, SD. 

Delaware Senate Unanimously Passes Legislation to Ensure Patient Access to Interchangeable Biologic Medicines

Apr 10 2014
BIO and Delaware Bio commend the Delaware State Senate for unanimously passing legislation yesterday designed to create a pathway for the substitution of interchangeable biologic medicines. 

BIO Applauds Introduction of the Safe and Accurate Food Labeling Act

Apr 9 2014
Consumer-focused legislation will enhance transparency and advance food safety Washington, D.C. (April 9, 2014) – The Biotechnology Industry Organization (BIO), applauds today’s introduction of the Safe and Accurate Food Labeling Act, which would establish a federal standard for the safety and labeling of food and beverage products made with genetically modified ingredients (GMOs).

Biotech Leader Testifies at Congressional Hearing on Legislative Proposals to Enhance Capital Formation for Small and Emerging Growth Companies

Apr 9 2014
The House Subcommittee on Capital Markets and Government Sponsored Enterprises held a hearing titled “Legislative Proposals to Enhance Capital Formation for Small and Emerging Growth Companies.” Brian Hahn, Chief Financial Officer of GlycoMimetics, Inc. presented testimony at the hearing on enhancements to the capital markets that can increase access to investors and decrease unnecessary regulatory burdens for emerging biotech companies trading on the public market.

The Biotechnology Industry Organization and Biominas Brasil to Co-Host First Ever BIO Latin America Conference

Apr 8 2014
BIO Latin American Conference will bring together biotechnology executives, academics and investors from around the globe